Investor Relations
Thursday 25 April 2024
Q1 2024 results
Key facts
Epidemiology
Contacts
Latest aide memoire
Upcoming events
Stewardship roadshow 2024 with Michel Demaré, London [Management]
JPM, ESG series fireside chat, Virtual [IR]
Annual Reports
Archive
Investor enquiries
Main Contacts
Andy Barnett
Head of Investor Relations
Isabel Gibson
Oncology
Christer Gruvris
BioPharmaceuticals
(Cardiovascular, Renal and Metabolism),
Finance & Fixed Income
Rachel Korolyshun
Rare Disease,
Environment, Social and Governance
Morgan Sanford
Oncology
Philip Sparks
BioPharmaceuticals
(Respiratory & Immunology, Vaccines & Immune Therapies)
Lauren Swales
Rare Disease,
Environment, Social and Governance
-
Shareholder information
Please find relevant shareholder information and shareholder tools on this page
-
Shareholder FAQs
Answers to frequently asked shareholder questions
-
Governance
We apply the principles of good corporate governance in the UK Corporate Governance Code and related guidance
